Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 4/2017

01-04-2017 | Gynecologic Endocrinology and Reproductive Medicine

Effects of a hyperandrogenaemic state on the proliferation and decidualization potential in human endometrial stromal cells

Authors: Alexander Freis, Tobias Renke, Ulrike Kämmerer, Julia Jauckus, Thomas Strowitzki, Ariane Germeyer

Published in: Archives of Gynecology and Obstetrics | Issue 4/2017

Login to get access

Abstract

Objective

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women, involving hyperandrogenaemia and insulin resistance. Treatment options include dexamethasone, as well as the off-label use of metformin. To evaluate the impact of those drugs on cyclic changes in endometrial development, we tested possible effects of metformin and dexamethasone on endometrial stromal cells decidualisation, proliferation, and gene regulation in a hyperandrogenaemic microenvironment in vitro.

Methods/design

Ten endometrial biopsies (of which five were decidualized in vitro) were used from regularly cycling women. Cells were treated with testosterone, dexamethasone, and metformin in different concentrations. Thereafter, cells were assessed for proliferation and decidualization capacity, as well as mTor and MMP-2 gene regulation.

Results

Metformin showed a dose-dependent negative effect on prolactin secretion, a known decidualization marker. This effect was stronger in a hyperandrogenaemic condition and could not be compensated by dexamethasone. Testosterone had a dose dependent negative effect on proliferation in decidualized endometrial stromal cells. Dexamethasone slightly compensated the negative proliferative effect only in low-dose testosterone. High-dose metformin also showed a dose-dependent reduction in endometrial stromal cell proliferation without a major impact by testosterone or dexamethasone in decidualized and non-decidualized cells. High-dose metformin significantly reduced the expression of matrix metalloproteinase-2 (MMP-2) and mechanistic Target of Rapamycin (mTor), regardless of the concentration of dexamethasone and testosterone. The strongest effect could be observed for the combination with high-dose dexamethasone.

Conclusion

When therapies, such as metformin and dexamethasone, are used to normalize peripheral androgen levels in patients with PCOS, their effect on the endometrial microenvironment should be taken into consideration as well, especially metformin has to be used with caution because of its dose dependent, possibly inhibiting effect at the endometrial proliferation.
Literature
1.
go back to reference Hackbart KS, Cunha PM, Meyer KM, Wiltbank MC (2013) Effect of Glucocorticoid-Induced Insulin Resistance on Follicle Development and Ovulation. Biol Reprod 88(6):153 (1–12)CrossRefPubMedPubMedCentral Hackbart KS, Cunha PM, Meyer KM, Wiltbank MC (2013) Effect of Glucocorticoid-Induced Insulin Resistance on Follicle Development and Ovulation. Biol Reprod 88(6):153 (1–12)CrossRefPubMedPubMedCentral
2.
go back to reference Huang Y, Li W, Wang CC, Wu X, Zheng J (2014) Cryptotanshinone reverses ovarian insulin resistance in mice through activation of insulin signaling and the regulation of glucose transporters and hormone synthesizing enzymes. Fertil Steril 102(2):589–596.e4CrossRefPubMed Huang Y, Li W, Wang CC, Wu X, Zheng J (2014) Cryptotanshinone reverses ovarian insulin resistance in mice through activation of insulin signaling and the regulation of glucose transporters and hormone synthesizing enzymes. Fertil Steril 102(2):589–596.e4CrossRefPubMed
5.
go back to reference Esmaeilzadeh S, Golsorkhtabar A, Basirat Z, Shirazi M (2011) Does Adding Dexamethasone to Clomiphene Citrate Improve Ovulation in PCOS Patients? A Triple—Blind Randomized Clinical Trial Study. Int J Fertil Steril 5:9–12PubMedPubMedCentral Esmaeilzadeh S, Golsorkhtabar A, Basirat Z, Shirazi M (2011) Does Adding Dexamethasone to Clomiphene Citrate Improve Ovulation in PCOS Patients? A Triple—Blind Randomized Clinical Trial Study. Int J Fertil Steril 5:9–12PubMedPubMedCentral
6.
go back to reference Heng S, Dynon K, Li Y, Edgell T, Rombauts LJ, Vollenhoven B and Nie G (2014) Development of a high throughput assay for human proprotein convertase 5/6 for detecting uterine receptivity. Anal Biochem. doi:10.1016/j.ab.2014.12.012 PubMed Heng S, Dynon K, Li Y, Edgell T, Rombauts LJ, Vollenhoven B and Nie G (2014) Development of a high throughput assay for human proprotein convertase 5/6 for detecting uterine receptivity. Anal Biochem. doi:10.​1016/​j.​ab.​2014.​12.​012 PubMed
7.
go back to reference Timeva T, Shterev A, Kyurkchiev S (2014) Recurrent implantation failure: the role of the endometrium. J Reprod Infertil 15(4):173–183PubMedPubMedCentral Timeva T, Shterev A, Kyurkchiev S (2014) Recurrent implantation failure: the role of the endometrium. J Reprod Infertil 15(4):173–183PubMedPubMedCentral
9.
go back to reference Schulte MM, Tsai J, Moley KH (2015) Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation. Reprod Sci 22(1):6–14CrossRefPubMedPubMedCentral Schulte MM, Tsai J, Moley KH (2015) Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation. Reprod Sci 22(1):6–14CrossRefPubMedPubMedCentral
10.
go back to reference Kim JY, Song H, Kim H, Kang HJ, Jun JH, Hong SR, Koong MK, Kim IS (2009) Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 94(4):1416–1426CrossRefPubMedPubMedCentral Kim JY, Song H, Kim H, Kang HJ, Jun JH, Hong SR, Koong MK, Kim IS (2009) Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 94(4):1416–1426CrossRefPubMedPubMedCentral
11.
go back to reference Maliqueo MA, Quezada S, Clementi M, Bacallao K, Anido M, Johnson C, Vega M (2004) Potential action of androstenedione on the proliferation and apoptosis of stromal endometrial cells. Reprod Biol Endocrinol 10(2):81CrossRef Maliqueo MA, Quezada S, Clementi M, Bacallao K, Anido M, Johnson C, Vega M (2004) Potential action of androstenedione on the proliferation and apoptosis of stromal endometrial cells. Reprod Biol Endocrinol 10(2):81CrossRef
12.
go back to reference Tuckerman EM, Okon MA, Li T, Laird SM (2000) Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril 74(4):771–779CrossRefPubMed Tuckerman EM, Okon MA, Li T, Laird SM (2000) Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril 74(4):771–779CrossRefPubMed
13.
go back to reference Okon MA, Laird SM, Tuckerman EM, Li TC (1998) Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril 69(4):682–690CrossRefPubMed Okon MA, Laird SM, Tuckerman EM, Li TC (1998) Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril 69(4):682–690CrossRefPubMed
14.
go back to reference Jalali Tehrani H, Parivar K, Ai J, Kajbafzadeh A, Rahbarghazi R, Hashemi M and Sadeghizadeh M (2014) Effect of dexamethasone, insulin and EGF on the myogenic potential on human endometrial stem cell. Iran J Pharm Res 13(2):659–664PubMedPubMedCentral Jalali Tehrani H, Parivar K, Ai J, Kajbafzadeh A, Rahbarghazi R, Hashemi M and Sadeghizadeh M (2014) Effect of dexamethasone, insulin and EGF on the myogenic potential on human endometrial stem cell. Iran J Pharm Res 13(2):659–664PubMedPubMedCentral
15.
go back to reference Elnashar A, Abdelmageed E, Fayed M, Sharaf M (2006) Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study. Hum Reprod 21(7):1805–1808CrossRefPubMed Elnashar A, Abdelmageed E, Fayed M, Sharaf M (2006) Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study. Hum Reprod 21(7):1805–1808CrossRefPubMed
16.
go back to reference Davies S, Dai D, Pickett G, Leslie KK (2006) Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cells. Gynecol Oncol 101(1):62–70CrossRefPubMed Davies S, Dai D, Pickett G, Leslie KK (2006) Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cells. Gynecol Oncol 101(1):62–70CrossRefPubMed
17.
go back to reference Makrigiannakis A, Margioris AN, Chatzaki E, Zoumakis E, Chrousos GP, Gravanis A (1999) The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells. Mol Hum Reprod 5(9):789–96CrossRefPubMed Makrigiannakis A, Margioris AN, Chatzaki E, Zoumakis E, Chrousos GP, Gravanis A (1999) The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells. Mol Hum Reprod 5(9):789–96CrossRefPubMed
18.
go back to reference Ibáñez L, Potau N, Marcos MV, de Zegher F (1999) Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche. J Clin Endocrinol Metab 84(12):4602–4606CrossRefPubMed Ibáñez L, Potau N, Marcos MV, de Zegher F (1999) Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche. J Clin Endocrinol Metab 84(12):4602–4606CrossRefPubMed
19.
go back to reference Maia-Filho VO, Rocha AM, Ferreira FP, Bonetti TC, Serafini P, Motta EL (2014) Matrix metalloproteinases 2 and 9 and e-cadherin expression in the endometrium during the implantation window of infertile women before in vitro fertilization treatment. Reprod Sci 22(4):416–422CrossRefPubMedPubMedCentral Maia-Filho VO, Rocha AM, Ferreira FP, Bonetti TC, Serafini P, Motta EL (2014) Matrix metalloproteinases 2 and 9 and e-cadherin expression in the endometrium during the implantation window of infertile women before in vitro fertilization treatment. Reprod Sci 22(4):416–422CrossRefPubMedPubMedCentral
20.
go back to reference Van der Stehen PE, Dubois B, Inge Nelissen, Rudd PM, DWEK AR, Obdenakker G (2002) Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37(6):375–536. doi:10.1080/10409230290771546 CrossRef Van der Stehen PE, Dubois B, Inge Nelissen, Rudd PM, DWEK AR, Obdenakker G (2002) Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37(6):375–536. doi:10.​1080/​1040923029077154​6 CrossRef
21.
go back to reference Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J (2001) Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69(6):851–859PubMed Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J (2001) Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69(6):851–859PubMed
22.
go back to reference Wang Y, Zhu L, Kuokkanen S, Pollard JW (2015) Activation of protein synthesis in mouse uterine epithelial cells by estradiol-17β is mediated by a PKC-ERK1/2-mTOR signaling pathway. Proc Natl Acad Sci USA 112(11):E1382–91CrossRefPubMedPubMedCentral Wang Y, Zhu L, Kuokkanen S, Pollard JW (2015) Activation of protein synthesis in mouse uterine epithelial cells by estradiol-17β is mediated by a PKC-ERK1/2-mTOR signaling pathway. Proc Natl Acad Sci USA 112(11):E1382–91CrossRefPubMedPubMedCentral
24.
go back to reference Margioula-Siarkou C, Prapas Y, Petousis S, Milias S, Ravanos K, Kalogiannidis I, Mavromatidis G, Haitoglou C, Prapas N, Rousso D (2016) LIF and LIF-R expression in the endometrium of fertile and infertile women: a prospective observational case-control study. Mol Med Rep 13(6):4721–4728PubMed Margioula-Siarkou C, Prapas Y, Petousis S, Milias S, Ravanos K, Kalogiannidis I, Mavromatidis G, Haitoglou C, Prapas N, Rousso D (2016) LIF and LIF-R expression in the endometrium of fertile and infertile women: a prospective observational case-control study. Mol Med Rep 13(6):4721–4728PubMed
26.
go back to reference Savaris RF, Groll JM, Young SL, DeMayo FJ, Jeong JW, Hamilton AE, Giudice LC, Lessey BA (2011) Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. J Clin Endocrinol Metab 96(6):1737–1746CrossRefPubMedPubMedCentral Savaris RF, Groll JM, Young SL, DeMayo FJ, Jeong JW, Hamilton AE, Giudice LC, Lessey BA (2011) Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. J Clin Endocrinol Metab 96(6):1737–1746CrossRefPubMedPubMedCentral
27.
go back to reference Fox C, Morin S, Jeong JW, Scott RT Jr, Lessey BA (2016) Local and systemic factors and implantation: what is the evidence? Fertil Steril 105(4):873–884CrossRefPubMed Fox C, Morin S, Jeong JW, Scott RT Jr, Lessey BA (2016) Local and systemic factors and implantation: what is the evidence? Fertil Steril 105(4):873–884CrossRefPubMed
28.
go back to reference Vanky E, Salvesen KA, Carlsen SM (2004) Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin. Hum Reprod 3(3):529–533CrossRef Vanky E, Salvesen KA, Carlsen SM (2004) Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin. Hum Reprod 3(3):529–533CrossRef
29.
go back to reference Jung ML Renke T, Nowak O, Jauckus J, Zorn M, Capp E, Strowitzki T, Germeyer A (2015): Modulation of the IGF system and proliferation in human endometrial stromal cells by metformin: a dose-dependent effect. Arch Gynecol Obstet 292(2):465–472CrossRefPubMed Jung ML Renke T, Nowak O, Jauckus J, Zorn M, Capp E, Strowitzki T, Germeyer A (2015): Modulation of the IGF system and proliferation in human endometrial stromal cells by metformin: a dose-dependent effect. Arch Gynecol Obstet 292(2):465–472CrossRefPubMed
30.
go back to reference Obara A, Fujita Y, Abudukadier A, Fukushima T, Oguri Y, Ogura M, Harashima S, Hosokawa M, Inagaki N (2015): DEPTOR-related mTOR suppression is involved in metformin’s anti-cancer action in human liver cancer cells. Biochem Biophys Res Commun 460(4):1047–1052CrossRefPubMed Obara A, Fujita Y, Abudukadier A, Fukushima T, Oguri Y, Ogura M, Harashima S, Hosokawa M, Inagaki N (2015): DEPTOR-related mTOR suppression is involved in metformin’s anti-cancer action in human liver cancer cells. Biochem Biophys Res Commun 460(4):1047–1052CrossRefPubMed
31.
go back to reference Shen C, Kim MR, Noh JM, Kim SJ, Ka SO, Kim JH, Park BH, Park JH (2016) Glucocorticoid Suppresses Connexin 43 Expression by Inhibiting the Akt/mTOR Signaling Pathway in Osteoblasts. Calcif Tissue Int 99:88–97CrossRefPubMed Shen C, Kim MR, Noh JM, Kim SJ, Ka SO, Kim JH, Park BH, Park JH (2016) Glucocorticoid Suppresses Connexin 43 Expression by Inhibiting the Akt/mTOR Signaling Pathway in Osteoblasts. Calcif Tissue Int 99:88–97CrossRefPubMed
32.
go back to reference Legro RS (2016) Ovulation induction in polycystic ovary syndrome: current options. Best Pract Res Clin Obstet Gynaecol 37:152–159CrossRefPubMed Legro RS (2016) Ovulation induction in polycystic ovary syndrome: current options. Best Pract Res Clin Obstet Gynaecol 37:152–159CrossRefPubMed
Metadata
Title
Effects of a hyperandrogenaemic state on the proliferation and decidualization potential in human endometrial stromal cells
Authors
Alexander Freis
Tobias Renke
Ulrike Kämmerer
Julia Jauckus
Thomas Strowitzki
Ariane Germeyer
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 4/2017
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4295-y

Other articles of this Issue 4/2017

Archives of Gynecology and Obstetrics 4/2017 Go to the issue